✦ LIBER ✦

Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy

✍ Scribed by Shehzad Basaria; Denis C. Muller; Michael A. Carducci; Josephine Egan; Adrian S. Dobs

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 292 KB
Volume: 106
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.21642

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Osteoporosis in men with prostate carcin

Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy : Recommendations for diagnosis and therapies

✍ Terrence H. Diamond; Celestia S. Higano; Matthew R. Smith; Theresa A. Guise; Fre 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 2 views

## Abstract ## BACKGROUND Androgen‐deprivation therapy (ADT) is prescribed with increasing frequency for men with prostate carcinoma. There is growing concern about the effects of such therapy on the skeleton. In the current review, the authors addressed the current research, diagnostic methods, a

Estradiol and cognition during androgen

Estradiol and cognition during androgen deprivation in men with prostate carcinoma

✍ Eeva K. Salminen; R.I. Portin; A.I. Koskinen; H.Y.M. Helenius; M.J. Nurmi 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 1 views

Estradiol and cognition during androgen

Estradiol and cognition during androgen deprivation in men with prostate carcinoma

✍ Richard J. Wassersug; Dolly Wadhwa 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 48 KB 👁 1 views

Natural history of bone complications in

Natural history of bone complications in men with prostate carcinoma initiating androgen deprivation therapy

✍ Tracey L. Krupski; Matthew R. Smith; Won Chan Lee; Chris L. Pashos; Jane Brandma 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 1 views

## Background: As evidence accumulates in favor of androgen deprivation therapy (adt) in patients with recurrent or metastatic prostate carcinoma, concern has increased regarding bone loss associated with therapeutic hypogonadism. the current study described the natural history of bone complication

Androgen deprivation therapy increases c

Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer

✍ Christopher S. Saigal; John L. Gore; Tracey L. Krupski; Janet Hanley; Matthias S 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

## Abstract ## BACKGROUND. The use of androgen deprivation therapy (ADT) in the treatment of men with prostate cancer has risen sharply. Although cardiovascular disease is the most common reason for death among men with prostate cancer who do not die of the disease itself, data regarding the effec

Low bone density and high percentage of

Low bone density and high percentage of body fat among men who were treated with androgen deprivation therapy for prostate carcinoma

✍ Zhao Chen; Michael Maricic; Paul Nguyen; Frederick R. Ahmann; Roberta Bruhn; Bru 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB 👁 1 views

## Abstract ## BACKGROUND Men with prostate carcinoma who are treated with androgen deprivation therapy (ADT) are reported to be at an increased risk of bone loss and weight changes due to the sudden disruption of hormonal levels. In the current case–control study, the authors examined the prevale